On July 22-26, Dr. Xun He and Juan Camilo Avendaño Diaz (PhD student) attended the 7th bi-annual Joint Action Meeting (JAM), held at Queen Mary University of London. This meeting brought together researchers from many different fields (psychologists, philosophers, physicists, musicians, engineers and neuroscientists, just to name a few), interested in studying people’s ability to act together (they had a full day covering human-robot interaction as well!).
Dr. Xun He gave a talk titled “A dual-EEG study of the shared attention effect in dyads: Sensory processing or top-down control?”, examining the information processing in the brain when people co-attend to the same spatial locations. Juan Camilo presented the poster “Visual attention in dyads: The role of group membership”, suggesting that co-attending with members of the same vs. different social group could have distinct effects on visual attention.
Attending JAM 2017 was a great opportunity to meet some key figures in the field, and to hear and discuss about the research that is been performed worldwide, including the research carried out at BU.
If you would like to learn more about our research, please do not hesitate to contact me at javendanodiaz@bournemouth.ac.uk











BU Prof Jonathan Parker promoting social work in Malaysia
New interdisciplinary paper accepted for publication
Three NIHR Internships awarded at BU
Research highlighted at the UN in New York
Poverty in the UK: book launch today at BU
BU contributions to successful Global Health conference
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease